isoimperatorin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, KS; Jung, YY; Kim, NY; Sethi, G; Um, JY; Yang, MH | 1 |
| Han, EH; Jeong, HG; Kang, KW; Kim, JY; Kim, SK; Oh, SJ; Pokharel, YR; Woo, ER | 1 |
2 other study(ies) available for isoimperatorin and Liver Neoplasms
| Article | Year |
|---|---|
Isoimperatorin down-regulates epithelial mesenchymal transition through modulating NF-κB signaling and CXCR4 expression in colorectal and hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Furocoumarins; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; NF-kappa B; Receptors, CXCR4; RNA; Signal Transduction | 2022 |
Potent protective effect of isoimperatorin against aflatoxin B1-inducible cytotoxicity in H4IIE cells: bifunctional effects on glutathione S-transferase and CYP1A.
Topics: Aflatoxin B1; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Cytochrome P-450 CYP1A1; Drugs, Chinese Herbal; Furocoumarins; Glutathione Transferase; Liver Neoplasms; Rats | 2006 |